{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:18:06Z","timestamp":1784557086491,"version":"3.55.0"},"reference-count":112,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["jme.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>Prolactin and prolactin receptor signaling and function are complex in nature and intricate in function. Basic, pre-clinical and translational research has opened up our eyes to the understanding that prolactin and prolactin receptor signaling function differently within different cellular contexts and microenvironmental conditions. Its multiple roles in normal physiology are subverted in cancer initiation and progression, and gradually we are teasing out the intricacies of function and therapeutic value. Recently, we observed that prolactin has a role in accelerating the time to bone metastasis in breast cancer patients and identified the mechanism by which prolactin stimulated breast cancer cell-mediated lytic osteoclast formation. The possibility that the prolactin receptor is a marker for metastasis, and specifically bone metastasis, is one that may have to be put into the context of the different variants of prolactin, different prolactin receptor isoforms and intricate signaling pathways that are regulated by the microenvironment. The more complete the picture, the better one can test biomarker identity and design clinical trials to test therapeutic intervention. This review will cover the recent advances and highlight the complexity of prolactin receptor biology.<\/jats:p>","DOI":"10.1530\/jme-16-0150","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T21:30:14Z","timestamp":1474579814000},"page":"R153-R165","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-6","source":"Crossref","is-referenced-by-count":35,"title":["Prolactin receptor in breast cancer: marker for metastatic risk"],"prefix":"10.1530","volume":"57","author":[{"given":"Carrie S","family":"Shemanko","sequence":"first","affiliation":[{"name":"Department of Biological SciencesCharbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2016101318242759000_57.4.R153.1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2002-0422"},{"key":"2016101318242759000_57.4.R153.2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0502"},{"key":"2016101318242759000_57.4.R153.3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M007478200"},{"key":"2016101318242759000_57.4.R153.4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306758200"},{"key":"2016101318242759000_57.4.R153.5","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070597"},{"key":"2016101318242759000_57.4.R153.6","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-008-9073-9"},{"key":"2016101318242759000_57.4.R153.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116891"},{"key":"2016101318242759000_57.4.R153.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.447631"},{"key":"2016101318242759000_57.4.R153.9","doi-asserted-by":"crossref","first-page":"48093","DOI":"10.18632\/oncotarget.10137","article-title":"Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells.","volume":"7","author":"Barcus","year":"2016","journal-title":"Oncotarget"},{"key":"2016101318242759000_57.4.R153.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00603-3"},{"key":"2016101318242759000_57.4.R153.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.36"},{"key":"2016101318242759000_57.4.R153.12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600537"},{"key":"2016101318242759000_57.4.R153.13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22971"},{"key":"2016101318242759000_57.4.R153.14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1528-y"},{"key":"2016101318242759000_57.4.R153.15","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1040"},{"key":"2016101318242759000_57.4.R153.16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11578"},{"key":"2016101318242759000_57.4.R153.17","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.406"},{"key":"2016101318242759000_57.4.R153.18","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1025302"},{"key":"2016101318242759000_57.4.R153.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.03.007"},{"key":"2016101318242759000_57.4.R153.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-008-9067-7"},{"key":"2016101318242759000_57.4.R153.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690799"},{"key":"2016101318242759000_57.4.R153.22","doi-asserted-by":"publisher","DOI":"10.1210\/en.140.1.96"},{"key":"2016101318242759000_57.4.R153.23","first-page":"695","article-title":"Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine\/paracrine loop","volume":"146","author":"Clevenger","year":"1995","journal-title":"American Journal of Pathology"},{"key":"2016101318242759000_57.4.R153.24","first-page":"41","article-title":"Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer","volume":"50","author":"Coskun","year":"2003","journal-title":"Neoplasma"},{"key":"2016101318242759000_57.4.R153.25","first-page":"E1216","article-title":"Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat","volume":"279","author":"Coss","year":"2000","journal-title":"American Journal of Physiology: Endocrinology and Metabolism"},{"key":"2016101318242759000_57.4.R153.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2011.12.010"},{"key":"2016101318242759000_57.4.R153.27","first-page":"1139","article-title":"Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells","volume":"13","author":"Das","year":"1996","journal-title":"Oncogene"},{"key":"2016101318242759000_57.4.R153.28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.174920"},{"key":"2016101318242759000_57.4.R153.29","doi-asserted-by":"crossref","first-page":"18267","DOI":"10.1016\/S0021-9258(17)32296-2","article-title":"Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors","volume":"269","author":"DaSilva","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"2016101318242759000_57.4.R153.30","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03738-1"},{"key":"2016101318242759000_57.4.R153.31","doi-asserted-by":"publisher","DOI":"10.1210\/en.142.12.5286"},{"key":"2016101318242759000_57.4.R153.32","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvg004"},{"key":"2016101318242759000_57.4.R153.33","doi-asserted-by":"publisher","DOI":"10.1210\/en.136.8.3512"},{"key":"2016101318242759000_57.4.R153.34","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.12.7.2171"},{"key":"2016101318242759000_57.4.R153.35","first-page":"4223","article-title":"Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer","volume":"24","author":"Frontini","year":"2004","journal-title":"Anticancer Research"},{"key":"2016101318242759000_57.4.R153.36","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0114"},{"key":"2016101318242759000_57.4.R153.37","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0130"},{"key":"2016101318242759000_57.4.R153.38","doi-asserted-by":"publisher","DOI":"10.1210\/me.10.7.847"},{"key":"2016101318242759000_57.4.R153.39","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0016"},{"key":"2016101318242759000_57.4.R153.40","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.473"},{"key":"2016101318242759000_57.4.R153.41","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9454-y"},{"key":"2016101318242759000_57.4.R153.42","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000178"},{"key":"2016101318242759000_57.4.R153.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.02.010"},{"key":"2016101318242759000_57.4.R153.44","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-12114-7_5"},{"key":"2016101318242759000_57.4.R153.45","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20141243"},{"key":"2016101318242759000_57.4.R153.46","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022166517963"},{"key":"2016101318242759000_57.4.R153.47","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2129"},{"key":"2016101318242759000_57.4.R153.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.12.031"},{"key":"2016101318242759000_57.4.R153.49","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2016.3472"},{"key":"2016101318242759000_57.4.R153.50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006146"},{"key":"2016101318242759000_57.4.R153.51","doi-asserted-by":"publisher","DOI":"10.1210\/me.15.5.832"},{"key":"2016101318242759000_57.4.R153.52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.50.35461"},{"key":"2016101318242759000_57.4.R153.53","doi-asserted-by":"publisher","DOI":"10.1210\/me.2001-0033"},{"key":"2016101318242759000_57.4.R153.54","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp120"},{"key":"2016101318242759000_57.4.R153.55","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.18.10664"},{"key":"2016101318242759000_57.4.R153.56","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2011.43.2.89"},{"key":"2016101318242759000_57.4.R153.57","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0490"},{"key":"2016101318242759000_57.4.R153.58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209214"},{"key":"2016101318242759000_57.4.R153.59","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.9.4038-4048.2004"},{"key":"2016101318242759000_57.4.R153.60","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-1274-4"},{"key":"2016101318242759000_57.4.R153.61","first-page":"1131","article-title":"A clinical study of taxotere vs taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines","volume":"22","author":"Lissoni","year":"2002","journal-title":"Anticancer Research"},{"key":"2016101318242759000_57.4.R153.62","first-page":"733","article-title":"Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline","volume":"23","author":"Lissoni","year":"2003","journal-title":"Anticancer Research"},{"key":"2016101318242759000_57.4.R153.63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010253107"},{"key":"2016101318242759000_57.4.R153.64","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22834"},{"key":"2016101318242759000_57.4.R153.65","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1432-1327.1998.2580784.x","article-title":"Selective coupling of STAT factors to the mouse prolactin receptor","volume":"258","author":"Mayr","year":"1998","journal-title":"European Journal of Biochemistry"},{"key":"2016101318242759000_57.4.R153.66","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2325"},{"key":"2016101318242759000_57.4.R153.67","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1019"},{"key":"2016101318242759000_57.4.R153.68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210264"},{"key":"2016101318242759000_57.4.R153.69","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0443"},{"key":"2016101318242759000_57.4.R153.70","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1312"},{"key":"2016101318242759000_57.4.R153.71","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0173"},{"key":"2016101318242759000_57.4.R153.72","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.11.046"},{"key":"2016101318242759000_57.4.R153.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.10.008"},{"key":"2016101318242759000_57.4.R153.74","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2731-7"},{"key":"2016101318242759000_57.4.R153.75","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2292"},{"key":"2016101318242759000_57.4.R153.76","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1533"},{"key":"2016101318242759000_57.4.R153.77","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0108"},{"key":"2016101318242759000_57.4.R153.78","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302910200"},{"key":"2016101318242759000_57.4.R153.79","doi-asserted-by":"publisher","DOI":"10.1210\/me.14.4.564"},{"key":"2016101318242759000_57.4.R153.80","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.3552"},{"key":"2016101318242759000_57.4.R153.81","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(97)00063-4"},{"key":"2016101318242759000_57.4.R153.82","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.35.24497"},{"key":"2016101318242759000_57.4.R153.83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.40.25043"},{"key":"2016101318242759000_57.4.R153.84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6094"},{"key":"2016101318242759000_57.4.R153.85","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2743-3"},{"key":"2016101318242759000_57.4.R153.86","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0964"},{"key":"2016101318242759000_57.4.R153.87","doi-asserted-by":"publisher","DOI":"10.1210\/me.2005-0291"},{"key":"2016101318242759000_57.4.R153.88","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-012-0168-0"},{"key":"2016101318242759000_57.4.R153.89","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0326"},{"key":"2016101318242759000_57.4.R153.90","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3232-z"},{"key":"2016101318242759000_57.4.R153.91","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206619"},{"key":"2016101318242759000_57.4.R153.92","unstructured":"Rui H Nevalainen MT 2003 Prolactin. In The Cytokine Handbook, 4th edn. Eds Thomson A Lotze M . London, UK: Academic Press. (doi:10.1038\/sj.onc.1206619)"},{"key":"2016101318242759000_57.4.R153.93","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.274"},{"key":"2016101318242759000_57.4.R153.94","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-221038"},{"key":"2016101318242759000_57.4.R153.95","doi-asserted-by":"publisher","DOI":"10.1210\/me.14.10.1592"},{"key":"2016101318242759000_57.4.R153.96","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkj109"},{"key":"2016101318242759000_57.4.R153.97","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208203"},{"key":"2016101318242759000_57.4.R153.98","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv338","article-title":"The role of prolactin in bone metastasis and breast cancer cell-mediated osteoclast differentiation","volume":"108","author":"Sutherland","year":"2016","journal-title":"Journal of the National Cancer Institute"},{"key":"2016101318242759000_57.4.R153.99","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:20:1-2:83"},{"key":"2016101318242759000_57.4.R153.100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fendo.2011.00029","article-title":"Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer","volume":"2","author":"Tallet","year":"2011","journal-title":"Frontiers in Endocrinology"},{"key":"2016101318242759000_57.4.R153.101","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0304"},{"key":"2016101318242759000_57.4.R153.102","doi-asserted-by":"publisher","DOI":"10.1677\/JME-09-0101"},{"key":"2016101318242759000_57.4.R153.103","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu150"},{"key":"2016101318242759000_57.4.R153.104","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0300031"},{"key":"2016101318242759000_57.4.R153.105","first-page":"1","article-title":"PRLR (prolactin receptor)","volume":"5","author":"Tsai-Morris","year":"2012","journal-title":"Atlas of Genetics and Cytogenetics in Oncology and Haemtaology"},{"key":"2016101318242759000_57.4.R153.106","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-4810"},{"key":"2016101318242759000_57.4.R153.107","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00350-08"},{"key":"2016101318242759000_57.4.R153.108","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/j.1460-2075.1994.tb06495.x","article-title":"Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response","volume":"13","author":"Wakao","year":"1994","journal-title":"EMBO Journal"},{"key":"2016101318242759000_57.4.R153.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.05.010"},{"key":"2016101318242759000_57.4.R153.110","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.25.15719"},{"key":"2016101318242759000_57.4.R153.111","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M000743200"},{"key":"2016101318242759000_57.4.R153.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.06.010"}],"container-title":["Journal of Molecular Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/jme.bioscientifica.com\/view\/journals\/jme\/57\/4\/R153.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jme.bioscientifica.com\/downloadpdf\/journals\/jme\/57\/4\/R153.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:53:02Z","timestamp":1784555582000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/jme\/article\/57\/4\/R153-R165\/11591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":112,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/jme-16-0150","relation":{},"ISSN":["0952-5041","1479-6813"],"issn-type":[{"value":"0952-5041","type":"print"},{"value":"1479-6813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}